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Abstract
Purpose Autonomic dysfunction is a known consequence of chronic and excessive alcohol consumption. The aim of this 
systematic review was to characterise this phenomenon, describe the frequency at which it occurs and to explore the best 
management strategies.
Methods A systematic, computer-based search was conducted using the PubMed database. All studies identiied by the 
search were evaluated independently by at least three authors. For inclusion, studies had to report human subjects consuming 
ethanol in excess. Case reports and non-original studies were excluded from this review.
Results A total of 55 studies were included in this review. According to cardiovascular relex tests, 16–73% of chronic alcohol 
abusers sufer from autonomic dysfunction. The most commonly occurring symptom is erectile dysfunction, whilst other 
features such as postural dizziness are rare. The most important risk factor for this condition is total lifetime dose of ethanol, 
although there is mixed evidence supporting the role of other risk factors. The only management strategy currently explored 
in the literature is abstinence, which appears to lead to signiicant improvement in autonomic investigations.
Conclusion Current literature includes studies of highly heterogeneous populations, consuming difering volumes of alcohol 
over variable periods of time and utilising a number of diferent autonomic test batteries and criteria to diagnose autonomic 
dysfunction. Therefore, further research using homogeneous methods for measuring autonomic dysfunction in the ield is 
needed. Despite this limitation, our review demonstrated that autonomic dysfunction is very common among alcohol abusers.
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Introduction
Chronic, excessive alcohol consumption is known to relate 
to diseases of both the central and peripheral nervous sys-
tem. Such manifestations include dementia, delirium tre-
mens, peripheral neuropathy and autonomic neuropathy [1, 
2]. With respect to somatic and autonomic nervous dam-
age, it is currently unclear whether the cause of dysfunction 
is the toxic impact of ethanol itself, or other confounding 
factors. However, for the purpose of this review the term 
“alcohol-related autonomic dysfunction” shall be used to 
indicate autonomic nervous system dysfunction related to 
chronic excessive alcohol use. The term “alcohol abuse” will 
be utilised henceforth to describe unhealthy, chronic, exces-
sive patterns of alcohol use.
Whilst somatic neuropathy more commonly presents 
symptomatically, autonomic dysfunction is another impor-
tant form of neurological compromise in the context of 
alcohol abuse and afects both the parasympathetic and 
sympathetic nervous system [3, 4]. Even in the absence 
of subjectively experienced phenomena, autonomic dys-
function is of clinical signiicance as it is associated with 
increased mortality [5]. At present, there is conlict in the 
literature in relation to the character of alcohol-related auto-
nomic dysfunction and its features are yet to be properly 
dissected.
The aim of this review is to consider the evidence base 
describing the nature of alcohol-related autonomic dys-
function as well as its frequency, risk factors, prognosis and 
management.
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Methods
Protocol registration
This review was prospectively registered to PROS-
PERO, an international prospective register of system-
atic reviews. The registration number for this review is 
CRD42018113087.
Literature search strategy
A systematic search was performed on 10 June 2018 using 
the PubMed database. For the search, two medical subject 
heading (MeSH) terms were used. Term A was “alcohol 
OR alcoholic OR ethanol”. Term B was “neuropathy OR 
polyneuropathy OR dysautonomia OR autonomic dys-
function”. Human subject and English language ilters 
were applied in our search. The reference lists of included 
articles were scanned for further articles which may fall 
within the scope of this review and were included where 
appropriate.
Inclusion and exclusion criteria
Articles eligible to be included in this review were required 
to meet the following criteria:
1. The article discussed autonomic dysfunction related to 
chronic alcohol consumption. Studies with any reported 
measure of symptoms or objective indings of autonomic 
dysfunction were included. Studies were not restricted 
on the basis of their speciic criteria for deining alcohol 
abuse.
2. The study was conducted using human subjects.
3. The article was written in English language.
Articles meeting the following criteria were excluded 
from our review:
1. Case reports.
2. Non-original articles (i.e. review articles, letters to the 
editor, expert opinion papers etc.).
3. Animal studies.
4. Duplicate articles (identical publications or referring to 
identical patient populations).
5. Studies of patient populations with other causes of auto-
nomic dysfunction or with comorbidities which may 
cause autonomic dysfunction (e.g., diabetes, vasculitis, 
mechanical trauma).
6. Studies referring to large ibre peripheral neuropathy 
alone.
7. Articles which could not be obtained despite university 
interlibrary request, British Library request, and inally 
an attempt to contact the article authors.
8. Studies which contained subjects who had consumed 
any forms of alcohol other than ethanol (e.g. methanol) 
or who consumed illegally manufactured or homemade 
alcohol, as these beverages are likely to contain impuri-
ties and may also be more toxic.
9. Articles detailing pilot treatments that have not been 
replicated or further conirmed with larger studies.
All article abstracts were screened in triplicate in a 
blinded fashion using Rayyan software. Those found to meet 
any of the exclusion criteria were removed and any conlicts 
were settled by consensus during a face-to-face meeting in 
which the abstracts were re-read. All remaining papers were 
screened again as a full article by at least two authors and 
conlicts were settled as previously described.
Data collection process
Data were extracted from each study in a structured coding 
scheme using Google Sheets and included population size, 
gender distribution, prevalence data, the nature of autonomic 
dysfunction, the means of diagnosis of autonomic dysfunc-
tion, risk factors, prognosis and response to treatment.
When there was uncertainty regarding how data should 
be interpreted or utilised, at least three authors discussed the 
study in question to ensure consensus.
Synthesis of results
This study is reported in accordance with the preferred 
reporting items for systematic reviews and meta-analysis 
(PRISMA) guidelines [6]. The data is presented numeri-
cally where possible. The synthesis of the data is descriptive.
Compliance with ethical guidelines
This article is based upon previously published studies. 
There are therefore no ethical concerns with regard to this 
study.
Results
Study characteristics
The aforementioned literature search produced a total of 700 
results. A total of 506 articles were excluded at the abstract 
screening stage. During the full paper eligibility assess-
ment stage, a further 143 studies were excluded. Four addi-
tional studies were identiied for inclusion by scanning the 
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reference lists of the identiied studies. Therefore, a total of 
55 studies published between 1966 and 2018 were included 
in the present review. The exclusion process and reasons for 
exclusion are detailed in Fig. 1.
Amongst the included studies were 40 cross-sectional 
studies, two case-control studies, 10 cohort studies and three 
case series. The total population of the included studies was 
2163; this total population does not include control subjects 
and does not include subjects who did not it the inclusion/
exclusion criteria.
Frequency of autonomic dysfunction
Autonomic test batteries utilised
For the most part, the studies identiied utilised non-invasive 
cardiovascular relex tests in order to measure autonomic 
dysfunction. In general, the investigations undertaken were 
as described by Ewing et al. including the heart rate (HR) 
response to the Valsalva test, standing and deep breathing 
(DBT), as well as blood pressure (BP) response to standing 
and sustained handgrip [7]. A minority of studies measured 
the HR response to atropine administration, HR response 
to baroreceptor stimulation by external suction, and 24-h 
heart rate variability (HRV) [5, 8–11]. Additional non-
cardiac measures of autonomic function identiied in this 
review include sympathetic skin response (SSR) and the 
methacholine test for iridic innervation [12–17]. The tests 
identiied in this review are summarised in Table 1. These 
investigations can be dichotomised to represent measures 
of sympathetic and parasympathetic function. Parasympa-
thetic tests include HR response to DBT, Valsalva test and 
standing. Sympathetic tests include sweat spot test, SSR, BP 
response to standing and BP response to sustained hand grip. 
The studies providing prevalence, symptoms and the split of 
parasympathetic and sympathetic dysfunction are provided 
in Table 2. A small number of tests assessed autonomic 
function using laser Doppler lowmetry, which demonstrated 
sympathetic dysfunction relative to controls [18–20].
Cardiovascular relex test abnormality
Amongst the identiied studies, there was a signiicant deal 
of heterogeneity with respect to the total consumption of 
alcohol within the cohort in question, deinitions of exces-
sive alcohol intake and alcohol dependency, autonomic 
batteries and deinitions of neuropathy utilised. Conse-
quently, the overall prevalence of autonomic neuropa-
thy amongst those who chronically abuse alcohol or are 
dependent upon alcohol cannot be produced by meta-anal-
ysis. Nonetheless, there is a signiicant body of research 
available, which supports a high rate of autonomic dys-
function amongst alcohol abusers with cardiovascular 
relex measures of neuropathy producing rates ranging 
between 16% and 73% [12, 21]. This range is clearly quite 
wide and explained by the heterogeneity between stud-
ies, and it is worth noting that the most methodologically 
sound study with amongst the largest studied populations 
established that 26% of the study population (patients 
satisfying DSM IV criteria for alcohol dependence) have 
abnormal cardiovascular relexes, deined as two or more 
abnormal parameters [22]. Interestingly, with respect to 
the cardiovascular system, parasympathetic impairment 
occurs with greater frequency than sympathetic, which is 
Fig. 1  A PRISMA chart detailing the exclusion/inclusion process
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less common and in most studies did not occur in isola-
tion—this is illustrated in Table 2 [8, 10, 22–26]. Cur-
rently, there are no relevant longitudinal studies with pro-
longed follow-up and therefore it cannot be ascertained 
whether this might represent a natural course in which 
most individuals begin with parasympathetic dysfunction 
and later develop sympathetic involvement as their con-
dition progresses. Despite the signiicant frequency with 
which cardiovascular relexes are deranged in alcohol 
abusers, this does not appear to translate into frequent car-
diovascular features with most studies reporting patients 
to be asymptomatic as detailed in Table 2.
Four studies utilised Holter monitors to measure 24-h 
heart rate variability (HRV) to detect depressed HRV 
related to autonomic dysfunction. Malpas et al. found that 
there were subtle changes in HRV in individuals who had 
normal cardiovascular relex tests, and thus proposed that 
HRV may indicate early ANS derangement amongst alcohol 
abusers [24]. Malpas et al. found a high rate of 24-h HRV 
abnormality, afecting 74% of subjects, 30% of which had 
cardiovascular relex test abnormality. Similarly, two papers 
by Weise et al. used mean momentary arrhythmia to meas-
ure HRV with a lower prevalence of 16% and 36% [21, 27]. 
One small study by Melgaard and Somnier failed to show 
a signiicant diference in beat-to-beat variation in alcohol 
abusers relative to controls (n = 14) [28].
Presently, the extensive literature described above in rela-
tion to cardiovascular relex tests represents the most com-
pelling evidence that those who consume large quantities of 
alcohol over a prolonged period of time are vulnerable to 
autonomic dysfunction.
Sympathetic skin response abnormality
Sympathetic skin response (SSR) in chronic alcohol abus-
ers was explored by three studies, two of which demon-
strated deranged sudomotor function in alcohol abusers 
with absent palm SSR in 6–13%, ingertip in 31% and foot 
SSR in 31–53% [12, 13]. Additionally, the results support 
that the dysfunction occurs in the most distal segments, an 
observation that has been shown in patients with alcohol-
related large ibre peripheral neuropathy [4]. Navarro et al. 
investigated the relationship between SSR and the number of 
pilocarpine-reactive sweat glands, inding that sympathetic 
involvement is associated with a decrease in their density 
[12]. However, conlicting these results, a study conducted 
by Tugnoli et al. failed to ind signiicant diferences in SSR 
between chronic alcohol abusers and healthy controls [14]. 
Table 1  Summary of autonomic tests utilised in papers identiied within the literature
The speciic igures deined as abnormal are not consistent. There is some variability as to how the above tests were conducted; the table 
describes the most common methodology applied
Autonomic parameter Description
HR response to Valsalva (Valsalva ratio) The subject blows into a mouthpiece at a pressure of 40 mmHg for 15 s. The ratio of the 
ratio of the longest R–R interval shortly after the manoeuvre to the shortest R–R interval 
during the manoeuvre is measured
HR response to deep breathing (deep breathing test) The subject breaths at a rate of six breaths per minute. The mean of the diferences 
between the maximum and minimum heart rate during the cycle of respiration is calcu-
lated
HR response to standing The subject lies on a couch, then stands unaided. The ratio of the longest R–R interval 
around the 30th beat and the shortest around the 15th beat is calculated
HR response to atropine IV atropine is administered. The maximum heart rate change following the infusion is 
calculated
HR response to baroreceptor stimulation The carotid baroreceptors are stimulated by negative pressure applied to the subject’s neck 
(− 50 mmHg). The pressure is applied for a few seconds. The longest R–R interval is 
measured
BP response to standing The BP is measured whilst the subject is lying down and then after standing up. The difer-
ence between these measures is calculated
BP response to sustained handgrip Handgrip is maintained at 30% of the maximum voluntary contraction using a handgrip 
dynamometer up to a maximum of 5 min. The diference between the diastolic BP before 
release of handgrip and just before starting is taken as the measure of response
Heart rate variability The R–R intervals are measured for 5 min at rest. The mean momentary arrhythmia is 
calculated
Sympathetic skin response Electrodes are attached to the skin surface. Electrical stimuli are delivered at long, irregu-
lar intervals to avoid habituation. The voltage of the skin response is measured
Methacholine test Pupillary diameter is measured. One drop of 2% methacholine in normal saline is instilled 
in each conjunctival sac. The lacrimal duct is occluded, and the pupillary diameter is 
remeasured after 20 min to identify constriction
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Table 2  Studies reporting the prevalence of abnormality in autonomic function parameters
Study Population size Deinition of alcohol abuse utilised Autonomic parameters Prevalence of autonomic neuropathy (%)
Rechlin et al. 1996 60 Satisied DSM-III-R criteria for alco-
hol dependence
Cardiovascular relex tests
  5-min recording of HR whilst supine
  HR response to deep breathing, the 
Valsalva test and standing to calcu-
late posture index   Coeicient of 
variation in HR whilst resting
Cardiovascular relex tests: 20% (≥ 3 
parameters abnormal)
Weise et al. 1986 11 Fulilled criteria of Munich alcohol-
ism test
Mean momentary arrhythmia (HRV) Mean momentary arrhythmia: 36% 
(value outside of control 95% CI)
Weise et al. 1985 31 Fulilled criteria of Munich alcohol-
ism test
Mean momentary arrhythmia (HRV) 
clinically determined by erectile 
dysfunction
Mean momentary arrhythmia: 16.1% 
(value outside of control 95% CI)
Erectile dysfunction: 23% of males
Di Ciaula et al. 2016 136 Satisied DSM-IV-TR criteria Sweat spot test 
Valsalva test
Sweat spot test abnormality (sympa-
thetic): 61%
Valsalva test R–R ratio (parasympa-
thetic): 40% (54/136)
Ferdinandis et al. 2006 23 Average daily ethanol consumption 
≥ 75 g in the previous 5 years 
with a score of ≥ 8 in the AUDIT 
questionnaire
Cardiovascular relex tests
  HR response to deep breathing, 
Valsalva test and standing
  BP response to standing
Cardiovascular relex tests: 44% (≥ 2 
abnormal tests)
Clinical features: 9%
Nicolosi et al. 2005 40 Consumption of ethanol of 100–400 g 
daily for 5–25 years
Cardiovascular relex tests
  HR response to DBT, Valsalva test 
and standing
  BP response to standing and sus-
tained handgrip
‘Deinite’ autonomic neuropathy: 32.5%
All had both sympathetic and parasym-
pathetic dysfunction
Early ANS impairment:
Additional 25%
Author-deined scoring system
Ravaglia et al. 2004 132 Satisied DSM-IV criteria Clinical features including impotence, 
chronic diarrhoea, postural dizziness
Cardiovascular relex tests
  HR response to DBT and standing
  BP response to standing
Erectile dysfunction: 17% of males
Other clinical signs: 0%
Cardiovascular relex tests: 26% (≥ 2/3 
tests abnormal) autonomic neuropathy 
was parasympathetic type in 13/18 and 
mixed in 5/18
Agelink et al. 1998 35 Satisied DSM-III-R criteria Cardiovascular relex tests
  5 min resting HRV
  HR response to DBT and standing to 
calculate posture index
  BP response to sustained handgrip
“Possible autonomic neuropathy”: 26% 
(≥ 1 abnormal parameter)
Parasympathetic dysfunction: 18%
Sympathetic dysfunction: 23%
Monforte et al. 1995 107 At least 100 g (male) or 80 g (female) 
ethanol consumed a day for 2 years
Symptoms assessed including erectile 
dysfunction, chronic diarrhoea and 
postural dizziness
Cardiovascular relex tests
  HR response to DBT, Valsalva test 
and standing
  BP response to handgrip and stand-
ing
Postural symptoms: 11%
Chronic diarrhoea: 19%
Erectile dysfunction 29% of males
Cardiovascular relex tests: 24% 
(26/107)
18/26 of these had parasympathetic 
neuropathy, 8/26 had sympathetic and 
3/26 were mixed
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Table 2  (continued)
Study Population size Deinition of alcohol abuse utilised Autonomic parameters Prevalence of autonomic neuropathy (%)
Luft et al. 1994 63 Fulilled criteria of Munich alcohol-
ism test
Symptoms assessed systematically 
Cardiovascular relex tests
  HR response to standing, DBT and 
Valsalva test
  BP response to standing and hand-
grip
Constipation: 0%
Erectile dysfunction: 2%
Cardiovascular relex parasympathetic 
impairment: 10%
Cardiovascular relex sympathetic 
impairment: 16%
Malpas et al. 1991 23 100−350 g of ethanol daily for 
10–40 years
Cardiovascular relex tests
  HR response to DBT, standing, 
Valsalva test and baroreceptor 
stimulation 
24 h HRV
Parasympathetic dysfunction: 30% 
Sympathetic neuropathy: 0% (≥ 2 abnor-
mal tests) 
24 h HRV abnormality: 74%
Villalta et al. 1989 70 ≥ 100 g of ethanol daily for more than 
2 years
Clinical features including postural 
hypotension, loss of sweating abil-
ity, sphincter disturbances, erectile 
dysfunction, nocturnal diarrhoea
Cardiovascular relex tests
  BP response to standing
  DBT
Clinical features: 7% (5/70). 3/5 erectile 
dysfunction, 3/5 nocturnal diarrhoea. 
None had sphincter disturbance or 
sweating abnormality 
Parasympathetic (DBT): 20%
Sympathetic (abnormal BP response to 
standing): 0%
Johnson and Robinson 1988 79 100–300 g ethanol daily for 
10–40 years
Cardiovascular relex tests
  BP response to standing
  HR response to standing
  Valsalva test
  DBT
  HR response to atropine
One abnormal test: 32%
≥ 2 abnormal tests: 28%
Barter and Tanner 1987 30 (note: 14 had liver disease) ≥ 80 g of ethanol daily. Mean duration 
of 24 years
Cardiovascular relex tests
  HR response to Valsalva test, DBT 
and standing
  BP response to standing and hand-
grip
Cardiovascular relex tests: 36%
Parasympathetic: 16%
Sympathetic: 0%
Mixed: 20%
Tan et al. 1985 16 100–300 g ethanol daily for 
10–40 years
Cardiovascular relex tests
  HR response to standing, DBT, Vals-
alva test and atropine
Cardiovascular relex tests: 19% (≥ 2 
tests abnormal)
Tan et al. 1984 11 100–300 g ethanol daily for 10+ years Cardiovascular relex tests
  HR response to standing, Valsalva 
test, DBT and atropine
Cardiovascular relex tests: 55%
Tan et al. 1983 10 (note: 6 had possible liver disease) Mean of 200 g of ethanol daily for 
15 years
Cardiovascular relex tests
  HR response to standing, Valsalva 
test, DBT and atropine
  BP response to standing
Cardiovascular relex tests: 40% 
Parasympathetic: 20%
Sympathetic: 0% 
Mixed: 20%
3
5
C
lin
ical A
u
to
n
o
m
ic R
e
se
arch
 (2
0
2
0
) 3
0
:2
9
–
4
1
 
1
 3
Table 2  (continued)
Study Population size Deinition of alcohol abuse utilised Autonomic parameters Prevalence of autonomic neuropathy (%)
Matikainen et al. 1986 28 No speciic igures supplied. Recruited 
patients were admitted for with-
drawal treatment
Cardiovascular relex tests
  HR response to Valsalva test, stand-
ing and DBT
  BP response to standing
Parasympathetic tests
  Chronic alcohol abusers had reduced 
parasympathetic function relative to 
healthy controls
Sympathetic tests
  The sympathetic nervous system was 
not signiicantly diferent between 
groups
Melgaard and Somnier 1981 14 Severe alcoholism over ≥ 10 years The number of ‘runs’ (increasing or 
decreasing R–R intervals) in 150 
consecutive measurements
Standard deviation and mean square 
successive diference of the R–R 
intervals
No abnormalities identiied compared 
with the control group
Duncan et al. 1980 20 100–300 g of ethanol over 12–40 years Cardiovascular relex tests
  HR response to standing, Valsalva 
test, DBT, baroreceptor stimulation 
and atropine
  BP response to standing
Parasympathetic neuropathy: 35% (≥ 2 
abnormal tests)
Sympathetic: 0%
Sebastian and Puranik 2018 30 (note: all had normal liver function 
tests)
Subjects had been consuming either 
6 alcoholic beverages or 90 ml of 
ethanol a day for 5 or more years
Cardiovascular relex tests
  BP response to standing, sustained 
handgrip and mental stress test
  Resting HR
  HR response to standing, deep 
breathing and Valsalva
  HR expiration/inspiration ratio
Parasympathetic tests
  Within normal range except for resting 
HR which was signiicantly increased 
compared to controls
Sympathetic tests
  There was a signiicant increase in BP 
response to standing and to handgrip
Myers et al. 1979 40 No description provided Cardiovascular relex tests
  BP response to standing
  HR response to standing and Vals-
alva test
Sweating abnormality in feet
Methacholine test
Metacholine test: 8%
Decreased sweating: 15%
Cardiovascular relex tests: 0%
Valls-Sole et al. 1990 70 ≥ 100 g daily for male, ≥ 80 g for 
female. Must have persisted for at 
least 2 years
SSR Palm SSR absent: 6%
Fingertip SSR absent: 31%
Foot SSR absent: 31%
Navarro et al. 1993 30 85–386 g of ethanol daily for 
4–41 years
SSR
SGN
Cardiovascular relex tests
  HR response to Valsalva test and 
DBT
Abnormal foot SGN: 60%
Abnormal hand SGN: 23%
Foot SSR absent: 53%
Palm SSR absent: 13%
Cardiovascular relex tests: 73%
DBT only: 40%
Valsalva test only: 53%
SSR sympathetic skin response, DBT deep breathing test, SGN number of secreting sweat glands, BP blood pressure, HR heart rate, HRV heart rate variability, ANS autonomic nervous system
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As the studies utilised diferent deinitions of excessive 
alcohol intake, it is possible that the contrasting indings 
are the result of dissimilar populations. It should also be 
noted that of the three studies, the population size studied 
by Tugnoli et al. was the smallest, with 20 subjects com-
pared with a pooled total of 100 individuals in the studies 
demonstrating diferences between chronic alcohol abus-
ers and healthy controls. Therefore, the evidence currently 
supports that deranged SSR is a feature of alcohol-related 
autonomic neuropathy. Clinically, however, the symptom of 
abnormal sweating is not one which is often highlighted 
as a signiicant feature in the literature which may indicate 
that this derangement is generally either subclinical or is not 
troubling to patients. This is illustrated in Table 2, in which 
most studies do not identify patients with this symptom with 
the exception of the article by Myers et al. in which 15% of 
patients had decreased sweating in the feet [17].
Erectile dysfunction
In males, erectile dysfunction appears to be a common fea-
ture afecting between 2–29% of chronic alcohol abusers 
[21, 25, 29, 30]. The relationship between alcohol abuse and 
erectile dysfunction was explored in greater detail by Wetter-
ling et al. who found that there was increasing frequency of 
this symptom with increased alcohol consumption [31]. The 
wide range of the reported prevalence of erectile dysfunction 
in alcohol abusers was in part due to the various lengths of 
time between alcohol withdrawal and the commencement of 
the study [30]. Whilst the frequency of erectile dysfunction 
in this patient cohort varies signiicantly between studies, it 
is consistently the most common symptom reported.
Gastrointestinal features
Previously, deranged gastrointestinal (GI) physiology and 
a number of related clinical features which often occur in 
chronic alcohol abusers have been attributed to autonomic 
neuropathy by some authors. Though there is little literature 
available on the topic, what is presently available does not 
seem to convincingly support the role of autonomic dysfunc-
tion in such derangements. The diiculty in assessing these 
features arises because it is challenging to disentangle the 
efects alcohol exerts on gut physiology, as well as direct 
toxic efects to the gastrointestinal organ system and ele-
ments of derangement which are attributed to autonomic 
dysfunction. Alcoholism has been linked to delayed oro-
cecal transit time, and gastric emptying [32–34]. Further, 
oesophageal dysmotility and lower oesophageal pressure 
changes have been identiied in this population, although 
these indings are not consistent [35–37].
With respect to symptomatology, heavy alcohol consump-
tion has been correlated with dyspepsia, nausea, abdominal 
pain and diarrhoea [33, 34]. Diarrhoea has been reported as 
a feature in alcohol abusers, but is not speciic to the ANS 
[25, 29].
It is also worth noting that in studies which identiied 
those with autonomic neuropathy using cardiovascular relex 
tests, a relationship between ANS dysfunction and gastro-
intestinal disorder is inconsistent and consequently it cur-
rently remains unclear whether changes to the GI system 
in the context of alcohol abuse are related to direct toxicity 
to smooth muscles, nervous dysfunction or some other sys-
temic efect [33, 34, 37].
Risk factors
Total lifetime dose of ethanol
Total lifetime dose of ethanol (TLDE) is often measured in 
studies to establish the extent of alcohol abuse. The TLDE 
is calculated by taking the daily alcohol consumption mul-
tiplied by 365 and by the number of years. This measure 
has been explored as a risk factor for the development of 
autonomic neuropathy.
Of the six studies to consider TLDE a risk factor, four 
reported that long-term alcohol abusers with evidence of 
cardiovascular autonomic dysfunction had a signiicantly 
higher TLDE than those without [2, 25, 29, 38]. Two of 
these only identiied a correlation with results from deep 
breathing tests [25, 29], and one found a correlation only 
with heart rate and blood pressure responses to standing 
[2]. The inal paper did not identify a correlation with any 
speciic investigation of cardiovascular autonomic dysfunc-
tions [38]. Only one paper by Ferdinandis and De Silva was 
unable to ind any correlation between the TLDE and cardio-
vascular autonomic dysfunction [39]. However, the TLDE 
is subject to a degree of recall bias and could be argued is 
particularly prone to under-reporting given the negative con-
notation regarding excessive alcohol consumption. Di Ciaula 
et al. considered gastrointestinal motility as a parameter for 
autonomic dysfunction and found a correlation between 
TLDE and gallbladder half-emptying time. They reported 
a lack of correlation between other measured parameters 
including gastric motility, dyspeptic scores and various gas-
trointestinal transit times [34].
Duration of alcohol abuse
Four studies speciically correlated the duration of alco-
hol abuse with presence of autonomic dysfunction through 
abnormal indings in cardiovascular parameters; however, 
the literature is conlicting [21, 22, 29, 38]. A study by 
Malpas et al. considered groups of chronic alcohol abusers 
with and without vagal neuropathies, inding no diferences 
between these groups with respect to duration of alcohol 
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abuse or age [24]. Furthermore, two studies showed no cor-
relation between either cardiovascular autonomic dysfunc-
tion or abnormal sympathetic skin response and duration of 
alcohol abuse, although these studies did not appear to adjust 
for age [40, 41]. Conversely, Agelink et al. showed duration 
of alcoholism to be one of the most important factors con-
tributing to the development of particularly sympathetic dys-
function, also demonstrating this independent of age [38].
Average daily alcohol intake
Three papers considered the efect of daily alcohol intake 
[29, 32, 33]. Papa et al. considered the efect of moderate 
and heavy alcohol consumption on intestinal transit times, 
finding that only heavy intake resulted in significantly 
increased transit times, which might indicate a visceral 
autonomic neuropathy. However, the authors highlighted the 
inability to draw a conclusion from this study as the intesti-
nal tract is likely to also experience direct toxic efects from 
alcohol [32]. Showing similar results, a study considering 
gastrointestinal transit in chronic alcohol abusers found there 
was a signiicant correlation between mean daily consump-
tion and gastric emptying times [33]. A single study evalu-
ated the efects of graduating levels of alcohol consumption 
on cardiovascular relex test parameters, and identiied no 
relationship between these variables [29].
Hepatic dysfunction
There is debate within the literature with respect to the 
role of hepatic dysfunction in alcohol-related autonomic 
dysfunction.
Compared to healthy controls, subjects with alcoholic cir-
rhosis have an increased incidence of autonomic dysfunction 
[42, 43]. In the largest study (n = 107) which investigated the 
role of alcohol-related diseases in autonomic dysfunction, no 
relationship was identiied between hepatic disease and auto-
nomic dysfunction [29]. This inding is supported by a fur-
ther seven smaller studies and provides strong evidence that 
hepatic disease is not a prerequisite for autonomic dysfunc-
tion in the context of chronic alcohol abuse [1, 22, 38, 40, 
44–46]. This is further illustrated by Sebastian and Puranik 
who performed a study in which they compared alcohol 
abusers with normal liver function to healthy controls and 
identiied signiicant sympathetic derangement and a higher 
resting heart rate but normal parasympathetic tests in those 
who heavily consumed alcohol, therefore further supporting 
the hypothesis that hepatic dysfunction is not essential to the 
disease process [47]. A single study of alcohol abusers with 
autonomic neuropathy found that these individuals are more 
likely to have alcoholic liver disease [26].
Five studies assessed cohorts of individuals with hepatic 
dysfunction of various aetiologies. In these studies, it is clear 
that those with liver disease have an increased prevalence 
of autonomic dysfunction, but that this is even higher in the 
context of alcoholic cause of liver disease [48–52]. This data 
implicates ethanol or some other confounding factor such 
as other health behaviours of those who abuse alcohol or 
a further substance contained in alcoholic beverages in the 
pathogenesis of autonomic dysfunction, in addition to any 
role which hepatic disease plays.
Weighing the available evidence, the most likely conclu-
sion at present is that autonomic dysfunction can occur in 
the absence of hepatic disease and therefore the latter is not 
central to the disease process. However, it is feasible that 
hepatic disease may play a role in the autonomic dysfunc-
tion of some alcohol-abusing individuals as a co-occurring 
pathological factor.
Nutrition
Four studies commented on the role of nutrition, all showing 
no correlation with alcohol-related autonomic dysfunction 
[22, 29, 38, 53]. Three of these studies assessed nutritional 
status through protein and caloric intake proiles, as well 
as body weight [22, 29, 38]. Two of these studies excluded 
malnourished patients, and noted that this therefore estab-
lishes that malnutrition is not required for the presence of 
autonomic dysfunction [22, 38]. Monforte et al. included 
patients with nutritional deiciency but did not demonstrate 
a relationship between nutritional status and autonomic 
neuropathy [29]. Similarly, Koike et al. considered the role 
of  B12 deiciency in other neurological disorders such as 
beriberi postulating that this vitamin may also impact upon 
the ANS in alcohol abusers, and therefore measured blood 
 B12 levels to exclude  B12 deiciency in the study population. 
In this study, autonomic dysfunction therefore occurred in 
the absence of  B12 deiciency, excluding this as a central 
requirement to the pathogenesis in patients in this study [53].
At present, there is inadequate exploration of serum 
vitamin levels in cohorts evaluated for alcohol-related auto-
nomic neuropathy and this prevents satisfactory assessment 
of this as a risk factor, or pathogenic factor for neuropathy.
Smoking
Only one study noted self-reported smoking habits in the 
context of autonomic dysfunction and found no correlation 
[29].
Age
Four studies, all assessing cardiovascular autonomic out-
comes, commented on age as a risk factor [22, 24, 29, 38]. 
There were no signiicant diferences between the mean ages 
of patients chronically abusing alcohol who did and did not 
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demonstrate autonomic dysfunction in these studies. Three 
studies found no relationship; however, one study conducted 
by Ravaglia et al. identiied a signiicant negative correlation 
with increasing age and heart rate response to deep breath-
ing, but did not appear to have adjusted for duration of alco-
hol abuse or TLDE [22]. This study also considered other 
parameters of cardiovascular, gastrointestinal autonomic 
dysfunction and impotence.
Sex
Only two studies, both assessing only cardiovascular auto-
nomic dysfunction, commented on sex as a risk factor. Nei-
ther found any relationship between sex and alcohol-related 
autonomic dysfunction [38, 40].
Central nervous system involvement
Interestingly, one paper commented on the increased inci-
dence of autonomic dysfunction in patients with encephalop-
athy. However, as a result of the small population sizes and 
the conlicting results, this correlation remains uncertain [1]. 
Speculatively, one may consider that this risk factor could 
relect a proxy for very high levels of alcohol consumption, 
hepatic impairment or other particularly sick state.
Physical itness
Only one study commented on the relationship between 
physical itness and autonomic dysfunction in alcohol abus-
ers and found an inverse relationship [54].
Ethnicity
Ethnicity was not explored as a risk factor for alcohol-related 
autonomic neuropathy in the available literature. However, 
it is feasible that this may be a risk factor because of the dif-
ferences between people of diferent ethnicities with regards 
to the metabolism of ethanol. Alcohol metabolism is deter-
mined primarily by the enzymes ADH, ALDH and CYP2E1 
[55]. These enzymes have numerous isoforms, which are 
associated with diferent ethnicities. ADH and ALDH alleles 
relate to enzymes which catalyse the formation of toxic 
metabolite acetaldehyde from ethanol thus potentially afect-
ing the risk of alcoholism and alcohol-related tissue damage 
[55, 56]. Similarly, the CYP2E1 isozyme has ethnic variance 
and inluences the metabolism of alcohol and blood alcohol 
levels. However, the inluence of various isozymes related 
to alcohol metabolism over one’s tendency to alcoholism or 
vulnerability to toxicity is an area of research currently con-
sidered to have results which are inconclusive [57]. There-
fore, ethnicity as a risk factor may represent an interesting 
area for future research.
Relationship between autonomic dysfunction 
and large ibre peripheral neuropathy
The literature described contrasting opinions on the rela-
tionship between autonomic dysfunction due to alcohol and 
alcohol-related large ibre peripheral neuropathy. A total 
of 35 papers commented on this relationship. The majority 
conclude that autonomic dysfunction and alcohol-related 
peripheral neuropathy can occur concurrently [2, 5, 8, 9, 11, 
12, 21, 22, 25, 26, 28, 29, 33, 36, 38, 40, 49, 52, 58–60]. The 
largest study reporting alcohol-related large ibre peripheral 
neuropathy in the context of autonomic dysfunction was 
done by Monforte et al. which recruited 107 alcohol abusers; 
41% of patients with large ibre neuropathy deined by elec-
trophysiological criteria had autonomic dysfunction, while 
15% of patients without peripheral neuropathy had auto-
nomic dysfunction [29]. Conversely, Johnson and Robinson 
led a study (n = 79) which described 64% of patients with 
two or more abnormal vagal nerve function tests and 56% of 
those with a single abnormal vagal test results as also having 
peripheral neuropathy identiied by clinical examination [5]. 
The igures often varied according to the type of autonomic 
dysfunction described. Gastrointestinal autonomic dysfunc-
tion did not usually occur in the presence of alcohol-related 
peripheral neuropathy but, as discussed earlier in the present 
review, autonomic dysfunction afecting the gastrointestinal 
system is challenging to explore [33, 36]. Only two studies 
found no co-occurrence between peripheral neuropathy and 
autonomic dysfunction [22, 44].
Management
Presently, the only discussed management strategy is absti-
nence, which appears to exert a positive impact, though the 
evidence base is weak. Hirsch et al. studied the efect of 
abstinence on respiratory sinus arrhythmia, inding a sig-
niicant improvement in subjects at 12 weeks follow-up 
(n = 17) [61]. Weise et al. studied the efect of abstinence on 
HRV in alcohol-abusing subjects with abstinence of at least 
6 months, inding a signiicant increase in HRV after absti-
nence (n = 11) [27]. Di Ciaula et al. found that there was a 
signiicant increase in sweat spot test results after 12 months 
of abstinence (n = 136) [34]. Villalta et al. studied cardiac 
response to DBT following 1 year of abstinence in 12 sub-
jects with initially abnormal results, demonstrating improve-
ment in 11 and results reaching the normal range in nine of 
these [25]. Finally, Tan et al. studied cardiovascular relex 
tests in chronic alcohol abusers 1–6 weeks after withdrawal, 
and again at 27 months, inding signiicant improvement in 
the total group and resolution of vagal neuropathy in four 
patients [10]. Considering these results, it can be concluded 
that autonomic neuropathy in the context of alcoholism may 
be at least partially reversible with prolonged abstinence.
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Prognosis
The data on the prognosis of alcoholic autonomic dysfunc-
tion was scarce. Several papers reported an increase in sud-
den death in patients with alcoholic autonomic dysfunction 
compared to healthy controls [5, 24, 25, 52]. However, it 
should be recognised that this may be just one factor in 
increasing relative mortality. The potential confounding 
efect of other alcohol-related conditions on mortality such 
as alcohol-related cardiomyopathy must also be considered 
[5, 24]. Beyond this, there is no current research which eval-
uates the natural history of this disease, the efect on quality 
of life or life expectancy.
Assessment of bias
This review contains observational studies only. These stud-
ies are at risk of describing phenomena other than causation, 
and it is feasible that there is a confounder which accounts 
for the relationship between high alcohol consumption and 
autonomic dysfunction. The included studies acquired data 
about the total alcohol consumption of subjects through 
patient history, and therefore there is a high risk of social 
desirability or recall bias. The included study populations 
were frequently sourced from rehabilitation units or during 
admission for alcohol-related disease, and therefore there is 
a risk of selection bias in that this sample population may 
not be representative of the total population. The exclusion 
process in the present review was conducted independently 
by three authors to reduce the risk of cognitive bias on our 
behalf.
Conclusions
The present review draws the following conclusions regard-
ing alcohol-related autonomic dysfunction:
• The findings of studies included in this review with 
respect to the prevalence of alcohol-related autonomic 
dysfunction vary greatly, with some studies identifying 
no changes in the ANS across populations of chronic 
alcohol abusers and the highest prevalence identiied in 
a population being 73%. The large range is likely indica-
tive of the heterogeneity in the studied populations with 
respect to alcohol consumption or comorbidity as well 
as variability in the autonomic test batteries utilised by 
investigators.
• Cardiovascular relex tests indicate that the parasympa-
thetic nervous system is much more frequently afected 
than the sympathetic system, and that the sympathetic 
system is rarely afected in isolation. It is unclear whether 
those with parasympathetic dysfunction progress to hav-
ing a mixed dysfunction with time and exposure.
• Often, autonomic dysfunction does not present with 
symptoms. Whilst heterogeneity in the data has prevented 
pooling of igures, the included studies commenting upon 
the symptomatic presentations of autonomic dysfunction 
consistently suggest that the most commonly occurring 
symptom in males is erectile dysfunction. Other symp-
toms of autonomic dysfunction are rare. At present, with 
a sparsity of available data it is challenging to make con-
ident assertions as to the most common presentations of 
this disease.
• The most important risk factor for alcohol-related auto-
nomic dysfunction is total lifetime dose of ethanol. This 
is an important observation as it demonstrates the value 
of alcohol cessation in the prevention of further auto-
nomic derangement. However, there are a number of fac-
tors presently unexplored in the literature that may merit 
research including ethnicity, oxidative stress and type of 
alcohol consumed.
• There are currently few studies addressing the most 
appropriate management strategy for autonomic dys-
function in the context of alcohol abuse. However, there 
is some evidence to suggest that abstinence may lead to 
signiicant improvement.
• Alcohol-related autonomic dysfunction is positively cor-
related with sudden death, though it is important to note 
that this may be due to other confounding factors.
• Future research should aim to use more standardised 
measures of chronic alcohol abuse and autonomic dys-
function. Additionally, perhaps future research might 
beneit from elimination of subjects with comorbidities 
and medication use, although this is clearly challenging 
because of the frequency at which alcohol abusers sufer 
deranged liver function speciically as well as numerous 
other medical disorders.
Limitations
There was an incredible deal of heterogeneity between stud-
ies included in this review with regard to the authors’ deini-
tions of excessive alcohol consumption, choice of autonomic 
test batteries and deinitions of autonomic dysfunction. Con-
sequently, the data does not lend itself to meta-analysis and 
it is diicult to directly compare studies.
No studies identiied by this review discussed the patho-
genesis of alcohol-related autonomic dysfunction.
Generally, the studies identiied in this review did not 
follow populations over time. This makes the natural course 
of autonomic dysfunction related to alcohol dependence dif-
icult to elucidate.
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A single database was utilised to conduct the literature 
search for this study. This may have caused some studies 
to be excluded. However, the authors checked the reference 
lists of every included study to identify additional seminal 
publications.
Of the included studies, 21/55 excluded patients taking 
medications which might impact upon either the autonomic 
nervous system, alcohol metabolism or other organ systems 
studied. The remaining studies did not speciically men-
tion this criterion. Two studies acknowledged that recruited 
patients were indeed taking drugs which could potentially 
afect the reliability of the results [40, 48]. Studies of the 
autonomic nervous system would be most accurate in drug-
naïve patients as numerous medications afect the autonomic 
nervous system or speciic organ systems addressed in this 
review. Additionally, medication use may further interfere 
with the results of included studies because drugs can impact 
upon the metabolism of alcohol and therefore upon the toxic 
efect which ethanol consumption exerts.
Data collected by included studies such as that relating to 
total alcohol consumption, symptoms and medical history 
were generally collected by self-reported questionnaire. This 
data is vulnerable to error and bias as previously discussed.
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